GOG-0262 Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer and an Imaging Study to Evaluate Treatment Response
Japan GOG 2012: Dose-Dense Chemotherapy and Neoadjuvant Chemotherapy for Ovarian Cancer
Ob.Gyn. News 2012/07/27: Superiority of Dose-Dense Chemo Upheld for Ovarian Cancer
Current Oncology 2011: Weekly paclitaxel in ovarian cancer—the latest success story
UCSF 2011/06/29: Ovarian Cancer Outcomes May Improve with “Dose-Dense” Chemotherapy
Lancet 2009: Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
USNews 2009/09/20: New Chemo Regimen May Benefit Ovarian Cancer Patients
Ovarian Cancer National Alliance 2011: IP vs Dose Dense Chemo Filgrastim (Neupogen)
GOG: Front-Line Therapy: Standards and Controversies
Sunday, August 02, 2015
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment